BioCentury
ARTICLE | Clinical News

Altrazeal regulatory update

March 21, 2011 7:00 AM UTC

Uluru submitted an abbreviated 510(k) application to FDA to expand Altrazeal's label to include the management and mitigation of pain. Uluru already markets the antimicrobial dressing incorporating th...